Reported Reactions

Devices › Device, neurovascular embolization

Device brand name · Cnv dcs coils

Presidio 18 - Cerecyte Microcoil: medical device reports filed with FDA

168 reports name it, 2012–2017. Manufacturer given most often on reports: Micrus Endovascular. Product code HCG.

168
device reports naming the brand
0% of all MAUDE reports · about 12 a year
0
reports, 12 months to August 2026
0 in the 12 months before
85.1%
classified as malfunction
73% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 168 reports that name the brand "Presidio 18 - Cerecyte Microcoil" (cnv dcs coils), received between March 2012 and October 2017; the manufacturer given most often on reports is Micrus Endovascular. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (85.1%) and injury (14.3%); across all device, neurovascular embolization reports (product code HCG) death is recorded in 2.4% and malfunction in 73%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are positioning failure (28%), stretched (17.9%) and premature activation (16.7%). The patient problems coded most often are aneurysm and vascular system (circulation), impaired. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Presidio 18 - Cerecyte Microcoil was received in the five years to August 2026; the latest was received in October 2017.

By year received

030592012: 3020122013: 2220132014: 5920142015: 1820152016: 2420162017: 152017

Event type and report source

Event type, as classified on the report

Death0%0
Injury14.3%24
Malfunction85.1%143
Other0%0
Not given0.6%1

Who filed the report

Manufacturer report100%168
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 26,252 reports carrying product code HCG. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Positioning failure4728%4.7%
Stretched3017.9%7.4%
Premature activation2816.7%5.6%
Physical resistance169.5%7.9%
Unraveled material116.5%2%
Failure to advance106%16.2%
Impedance problem63.6%0.2%
Material separation63.6%1%
Breakthe device broke53%5.7%
Kinkedthe tube or line kinked53%2.8%
Difficult to position42.4%1%
Entrapment of device42.4%0.4%
Detachment of device component31.8%8.1%
Material deformation31.8%2.8%
Retraction problem31.8%1%
Delivery system failure21.2%0.3%
Device issuea problem with the device21.2%0.6%
Fracturea broken bone21.2%2.3%
Material protrusion/extrusion21.2%0.4%
Separation failure21.2%3.8%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Aneurysm169.5%
Vascular system (circulation), impaired10.6%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasurePresidio 18 - Cerecyte MicrocoilProduct code HCGAll MAUDE reports
Reports16826,25226,136,888
Share of that pool—0.6%0%
Classified as death, per 1,000 reports0249
Classified as injury14.3%24%36.2%
Classified as malfunction85.1%73%62.3%
Filed by the manufacturer100%98.5%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code HCG

BrandReportsLatest 12 monthsClassified as death
Ruby Coil3,360260.1%
Penumbra Smart Coil2,78130.3%
Penumbra Coil 4001,45300.9%
POD Packing Coil1,062350%
Trufill Dcs Orbit Mini Complex Fill73501.6%
Ruby Coil Lp479130%
Pod406180%
Trufill Dcs Orbit Detachable Coils Complex39500.8%
Deltaplush - Cerecyte Microcoil39200.3%
Penumbra Smart Coil Detachment Handle31700%
Deltapaq - Cerecyte Microcoil29500%
Orbit Galaxy Detachable Coil System27300.4%
Optima Coil System255552%
Packing Coil LP235110%
Xtrasoft Orbit Galaxy Detachable Coil23501.3%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Presidio 18 - Cerecyte Microcoil reports

How many FDA reports name Presidio 18 - Cerecyte Microcoil?

168 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (85.1%) and injury (14.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

positioning failure (28%), stretched (17.9%), premature activation (16.7%), physical resistance (9.5%) and unraveled material (6.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Presidio 18 - Cerecyte Microcoil was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.